News and Updates

Confused by Long COVID study data? Learn how to evaluate clinical trials, understand primary endpoints, and spot reliable research for PASC treatments.

New research suggests GLP-1 agonists may help reduce addiction-related hospitalizations, but findings show the benefits disappear once patients stop use.

Essential recall notice: Steerable sheaths used in PFA procedures are being pulled due to safety risks. Read the latest clinical update for providers.

Recent FDA data reveals a surge in Q2 pharmaceutical and medical device recalls linked to packaging failures and labeling errors. Learn the critical impact.

Kolon TissueGene’s Invossa-K fails Phase III trial for knee osteoarthritis. Learn how this clinical setback impacts the future of gene therapy treatments.

A groundbreaking clinical trial reveals CAR T-cell therapy shows promise for treating AL amyloidosis by targeting the root cause of protein buildup.

Health Canada has approved a Phase II/III clinical trial for Thykamine™ to treat pediatric atopic dermatitis in patients aged 3 months to 17 years.

Explore the latest clinical data on systemic JAK inhibitors for vitiligo. Discover how this emerging treatment works, its efficacy, and vital safety protocols.

Eli Lilly invests $2.8 billion to pioneer psychedelic research, aiming to overcome the limitations of traditional clinical trial infrastructure.

New Phase 1 trial data reveals the safety and potential of iPSC-derived cell therapy to treat subacute spinal cord injuries and promote neural recovery.